Researchers test new way to track cancer treatment effectiveness
NCT ID NCT03963518
Summary
This study investigated whether measuring 'time until next treatment or death' is a good way to track how well cancer treatments work, compared to the traditional measure of overall survival. Researchers looked at 631 patients with advanced melanoma who were receiving immunotherapy drugs. The goal was to determine if this newer measurement method could provide meaningful information about treatment effectiveness more quickly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER TREATED WITH IMMUNE-CHECKPOINT INHIBITORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonié, Comprehensive Cancer Center
Bordeaux, France
Conditions
Explore the condition pages connected to this study.